Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2  (01-2010)

Period of time： 2010年2期

Publisher： Bentham Science Publishers

Founded in： 2007

Total resources： 27

E-ISSN： 2212-3334|4|2

ISSN： 1872-2148

Subject： T-1 Technology Status and Development

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2

Menu

Serum Amyloid A and Its Potential Physiological / Pathological Functions - an Overview of Patents

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 89-99

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

B Lymphocytes, Potent Antigen Presenting Cells for Preferential Expansion of Allo-Reactive FoxP3+ CD4 Regulatory T Cells

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 100-110

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Recent Patents in Diagnosis and Treatment for Inborn Errors of Metabolism

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 111-130

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dolichol: A Natural Biomarker of Aging Endowed With a Photoenhanced Highly-Effective Solar Filter Activity

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 131-137

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Asymptomatic Primary Hyperparathyroidism: Management and Implications

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 138-145

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-01 , pp. 146-152

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

HDL - Cholesterol: The New Target for Treatment

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 153-160

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Protein Modification by &bgr;-N-Acetyl Glucosamine (O-GlcNAc) in Insulin Signaling and Insulin Resistance

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 161-171

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Patent Selections:

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery,volume 4,issue 2 , Vol. 4, Iss. 2, 2010-06 , pp. 172-174

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 9 item(s)